EP2661263

USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    3.1.2012
  • :
    14.4.2021
  • :
    12700294.7
  • :
    2.1.2032
  • :
    USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY

3.1.2012
14.4.2021
  • :
    GW Pharma Limited
  • :
    Sovereign House, Histon Cambridge CB24 9BZ, GB
  • :
    Otsuka Pharmaceutical Co., Ltd.
  • :
    9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535, JP
  • :
    WHALLEY, Benjamin
  • :
    Reading RG6 6AP, GB
  • :
    WILLIAMS, Claire
  • :
    Reading RG6 6AP, GB
  • :
    STEPHENS, Gary
  • :
    Reading RG6 6AP, GB
  • :
    201100043
  • :
    4.1.2011
  • :
    GB
  • :
    GB2012050002
  • :
    3.1.2012
  • :
    A61K 31/05, A61K 31/19, A61K 31/4015, A61P 25/08